| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 725191 | 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol | 0.0147237897640499 | 0.34145468 |
| NSC 727212 | 11-[2'-N-Aminopropyl)-aminoethylidene]-5,6-dihydro-5-oxo-2,3 -dimethoxy-6-methyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoq uinoline | 0.0147237897640499 | 0.50699863 |
| NSC 734294 | Indenoisoquinoline derivative | 0.0147237897640499 | 0.73657589 |
| NSC 736914 | Null | 0.0147237897640499 | 0.47925596 |
| NSC 740385 | 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide | 0.0147237897640499 | 0.30162352 |
| NSC 740504 | 5,6-Dihydro-6-[3-(2-hydroxyethyl)amino-1-propyl]-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride | 0.0147237897640499 | 0.68775887 |
| NSC 747452 | 3,19-(4-Acetamido)benzylidineandrographolide | 0.0147237897640499 | 0.17091559 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0147237897640499 | 0.26701958 |
| NSC 748705 | Null | 0.0164116791870034 | 0.32681012 |
| NSC 752892 | N-[4-(4-Benzoylamino-pyrrolo[3,2-c]pyridin-1-yl)-phenyl]-4-(4-morpholin-4-yl)-3-trifluoromethylbenzamide | 0.0164116791870034 | 0.49645593 |